Deals & Capital Markets
GSK Bets $2.2 Billion on Food Allergy Breakthrough in First Major Deal Under New CEO
14h ago
You're signed outSign in or to get full access.
GSK (GSK) Earnings Call Transcripts
Browse quarterly earnings call transcripts for GSK.
Q3 2025
Oct 29, 2025
Q2 2025
Jul 30, 2025
Q1 2025
Apr 30, 2025
Q4 2024
Feb 5, 2025
Q3 2024
Oct 30, 2024